Achieve Life Sciences Inc SP4P-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:04 AM CET
4.40quote price arrow down-0.01 (-0.18%)
52 week range
1.99 - 7.42
Loading...
  • Open4.40
  • Day High4.40
  • Day Low4.40
  • Prev Close2.45
  • 52 Week High7.42
  • 52 Week High Date04/27/22
  • 52 Week Low1.99
  • 52 Week Low Date11/11/22

Key Stats

  • Market Cap47.97M
  • Shares Out9.71M
  • 10 Day Average Volume1,304
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change86.9

KEY STATS

  • Open4.40
  • Day High4.40
  • Day Low4.40
  • Prev Close2.45
  • 52 Week High7.42
  • 52 Week High Date04/27/22
  • 52 Week Low1.99
  • 52 Week Low Date11/11/22
  • Market Cap47.97M
  • Shares Out9.71M
  • 10 Day Average Volume1,304
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change86.9

RATIOS/PROFITABILITY

  • EPS (TTM)-4.07
  • P/E (TTM)-1.08
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Achieve Life Sciences Inc

 

Profile

MORE
Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company. The Company is engaged in development and commercialization of cytisinicline for smoking cessation and nicotine addiction. The Company’s product candidate, cytisinicline, is a naturally occurring plant-based alkaloid from the seeds of the Laburnum anagyroides plant. Cytisinicline is structurally similar to nicotine and a mechanism of action that is both agonistic and antagonistic. The Company is aid in...
Richard Stewart
Executive Chairman of the Board
John Bencich CPA
Chief Executive Officer, Director
Cindy Jacobs M.D., Ph.D.
President, Director, Chief Medical Officer
Jerry Wan
Principal Accounting Officer
Address
22722 29TH DR. SE, SUITE 100
Seattle, WA
98021
United States